title: Serum sickness following rabbit antithymocyte-globulin induction in a liver transplant recipient: case report and literature review.
abstract: Thymoglobulin (Genzyme, Cambridge, MA) is an antithymocyte globulin preparation used for induction immunosuppression therapy in solid organ transplantation. It is being utilized with increasing frequency in orthotopic liver transplantation (OLT) in an effort to minimize or delay the use of calcineurin inhibitors due to their inherent nephrotoxicity. Experience with thymoglobulin in OLT remains limited. We report a case of serum sickness in a patient who received thymoglobulin following OLT. The patient experienced intermittent fevers, polyarthralgia, and acute renal failure 9 days after completion of thymoglobulin administration. The patient's symptoms resolved rapidly and completely with a course of intravenous steroids. We review a set of diagnostic criteria for serum sickness and emphasize the importance of early recognition of the process. Early treatment of serum sickness with steroids or plasmapheresis is highly effective and can reduce unnecessary morbidity from this unusual sequela of induction immunosuppression with antithymocyte globulin.
authors: Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
authors: Andrew L
authors: AL
authors: Lundquist
authors: Ravi S
authors: RS
authors: Chari
authors: James H
authors: JH
authors: Wood
authors: Geraldine G
authors: GG
authors: Miller
authors: Heidi M
authors: HM
authors: Schaefer
authors: David S
authors: DS
authors: Raiford
authors: Kelly J
authors: KJ
authors: Wright
authors: D Lee
authors: DL
authors: Gorden
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000961:Antilymphocyte Serum; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D016031:Liver Transplantation; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011817:Rabbits; D012713:Serum Sickness / Q000209:etiology*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D005938:Glucocorticoids; C512542:thymoglobulin; D008775:Methylprednisolone